Medicare Enrolled

Dr. Anthony Izzo, D.O.

Neurology · Worcester, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
123 SUMMER ST STE 660, Worcester, MA 01608
5083639030
In practice since 2008 (18 years)
NPI: 1215198692 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Izzo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Izzo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Izzo

Dr. Anthony Izzo is a neurology specialist in Worcester, MA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Izzo performed 7,046 Medicare services across 737 unique beneficiaries.

Between the years covered by Open Payments, Dr. Izzo received a total of $55,523 from 50 pharmaceutical and/or device companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Izzo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 7% volume in MA $55,523 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,046
Medicare services
Top 7% in MA for neurology
737
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~391 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
6,200 $5 $13
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
316 $94 $393
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
124 $136 $540
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep.
102 $33 $200
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
57 $93 $500
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
57 $135 $515
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
42 $62 $239
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
41 $119 $500
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
39 $98 $330
New patient office visit, complex (60-74 min) 25 $150 $669
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
23 $45 $200
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
20 $96 $315
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$55,523
Total received (2018-2024)
Avg $7,932/year across 7 years
Top 10% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49,383 (88.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,572 (8.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,569 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,823
2023
$1,204
2022
$1,138
2021
$2,121
2020
$862
2019
$15,733
2018
$19,641

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
JAZZ PHARMACEUTICALS INC.
$13,362
Teva Pharmaceuticals USA, Inc.
$278
Lundbeck LLC
$186
HARMONY BIOSCIENCES LLC
$171
ABBVIE INC.
$144
Avadel CNS Pharmaceuticals, LLC
$75
SK Life Science, Inc.
$73
ARGENX US, INC.
$71
TG Therapeutics, Inc.
$62
Lilly USA, LLC
$59
Amneal Pharmaceuticals LLC
$54
Biogen, Inc.
$44
Novartis Pharmaceuticals Corporation
$35
CSL Behring
$29
Axsome Therapeutics, Inc.
$29
Celgene Corporation
$26
Inspire Medical Systems, Inc.
$25
Grifols USA, LLC
$25
ACADIA Pharmaceuticals Inc
$25
Eisai Inc.
$21
ZOLL Respicardia, Inc.
$15
PFIZER INC.
$15
Top 3 companies account for 93.3% of 2024 payments
All-time payments by company (2018-2024) ›
JAZZ PHARMACEUTICALS INC.
$30,824
Biogen, Inc.
$19,986
Jazz Pharmaceuticals Inc.
$800
ABBVIE INC.
$680
Teva Pharmaceuticals USA, Inc.
$369
HARMONY BIOSCIENCES LLC
$230
Lundbeck LLC
$221
Harmony Biosciences LLC
$168
ACADIA Pharmaceuticals Inc
$167
Amgen Inc.
$139
GENZYME CORPORATION
$117
Sunovion Pharmaceuticals Inc.
$113
SK Life Science, Inc.
$109
UCB, Inc.
$107
Celgene Corporation
$104
PFIZER INC.
$97
Biohaven Pharmaceuticals, Inc.
$92
Avadel CNS Pharmaceuticals, LLC
$75
ARGENX US, INC.
$71
CSL Behring
$64
Inspire Medical Systems, Inc.
$63
TG Therapeutics, Inc.
$62
Lilly USA, LLC
$59
Novartis Pharmaceuticals Corporation
$58
Genentech USA, Inc.
$54
Eisai Inc.
$54
Amneal Pharmaceuticals LLC
$54
Axsome Therapeutics, Inc.
$51
AstraZeneca Pharmaceuticals LP
$48
Neurocrine Biosciences, Inc.
$43
Mallinckrodt Hospital Products Inc.
$42
Biohaven Pharmaceutical Holding Company Ltd.
$37
Allergan, Inc.
$28
EISAI INC.
$27
Grifols USA, LLC
$25
Amylyx Pharmaceuticals, Inc.
$25
Medtronic, Inc.
$23
Alexion Pharmaceuticals, Inc.
$22
AbbVie Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
MDD US Operations, LLC
$21
Acorda Therapeutics, Inc
$20
IMPEL PHARMACEUTICALS INC.
$19
Avion Pharmaceuticals
$19
E.R. Squibb & Sons, L.L.C.
$18
LivaNova USA, Inc.
$18
EMD Serono, Inc.
$17
Kyowa Kirin, Inc.
$16
ZOLL Respicardia, Inc.
$15
Allergan Inc.
$11
Top 3 companies account for 93.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · Fintepla · Fycompa · GOCOVRI · Gamunex-C · Hizentra · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · KYNMOBI · LUMRYZ · Leqembi · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ongentys · QULIPTA · RELYVRIO · SUNOSI · SYNCHROMEDII · Sunosi · TECFIDERA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · WAKIX · Wakix · XYWAV · ZEPOSIA · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for neurology in MA.

Looking for a neurology specialist in Worcester?
Compare neurologists in the Worcester area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
54
Per 100K population
6.3
County median income
$93,561
Nearest hospital
ST VINCENT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Izzo is a mixed practice specialist, with above-average Medicare volume (top 7% in MA), with speaking/promotional industry engagement in the top 10% of MA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Izzo experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Izzo performed 6,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Izzo receive payments from pharmaceutical companies?
Yes. Dr. Izzo received a total of $55,523 from 50 companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Izzo's costs compare to other neurologists in Worcester?
Dr. Izzo's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Izzo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →